Morgan Stanley Better Therapeutics, Inc. Transaction History

Morgan Stanley

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Oct 27, 2022	BUY	$0.91 - $2.34 $85,507 - $219,875	93,964 Added 1044044.44%	93,973 $147,000
Q2 2022 Aug 15, 2022	BUY	$0.91 - $2.34 $85,507 - $219,875	93,964 Added 1044044.44%	93,973 $147,000
Q1 2022 Oct 27, 2022	SELL	$1.98 - $5.01 $186,048 - $470,759	-93,964 Reduced 99.99%	9 $0
Q1 2022 May 13, 2022	SELL	$1.98 - $5.01 $21 - $55	-11 Reduced 55.0%	9 $0
Q4 2021 Feb 14, 2022	BUY	$4.58 - $17.14 $91 - $342	20 New	20 $0

Ticker BTTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,743,000
Description
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional ...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.